Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Braz. j. microbiol ; 47(2): 381-388, Apr.-June 2016. tab, graf
Article Dans Anglais | LILACS | ID: lil-780828

Résumé

Abstract Pan-drug resistant Gram-negative bacteria, being resistant to most available antibiotics, represent a huge threat to the medical community. Colistin is considered the last therapeutic option for patients in hospital settings. Thus, we were concerned in this study to demonstrate the membrane permeabilizing activity of colistin focusing on investigating its efficiency toward those pan-drug resistant isolates which represent a critical situation. We determined the killing dynamics of colistin against pan-drug resistant isolates. The permeability alteration was confirmed by different techniques as: leakage, electron microscopy and construction of an artificial membrane model; liposomes. Moreover, selectivity of colistin against microbial cells was also elucidated. Colistin was proved to be rapid bactericidal against pan-drug resistant isolates. It interacts with the outer bacterial membrane leading to deformation of its outline, pore formation, leakage of internal contents, cell lysis and finally death. Furthermore, variations in membrane composition of eukaryotic and microbial cells provide a key for colistin selectivity toward bacterial cells. Colistin selectively alters membrane permeability of pan-drug resistant isolates which leads to cell lysis. Colistin was proved to be an efficient last line treatment for pan-drug resistant infections which are hard to treat.


Sujets)
Humains , Membrane cellulaire/métabolisme , Infections bactériennes à Gram négatif/microbiologie , Colistine/métabolisme , Multirésistance bactérienne aux médicaments , Bactéries à Gram négatif/métabolisme , Antibactériens/métabolisme , Tests de sensibilité microbienne , Membrane cellulaire/effets des médicaments et des substances chimiques , Perméabilité des membranes cellulaires , Infections bactériennes à Gram négatif/traitement médicamenteux , Colistine/pharmacologie , Bactéries à Gram négatif/isolement et purification , Bactéries à Gram négatif/effets des médicaments et des substances chimiques , Bactéries à Gram négatif/ultrastructure , Antibactériens/pharmacologie
SÉLECTION CITATIONS
Détails de la recherche